MTCO3P9

Across TCGA pan-cancer cohorts, MTCO3P9 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MTCO3P9 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MTCO3P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTCO3P9 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

SKCM, UVM, and THYM are the cancer types where MTCO3P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	IV	0.049	0.502	.002	45	view →
UVM	DFS	Tertile	All	0.032	0.762	<.001	45	view →
THYM	DFS	Tertile	All	0.075	0.885	<.001	27	view →
LIHC	DFS	Tertile	All	0.179	0.568	<.001	27	view →
KIRC	DFS	Tertile	IV	1.000	0.578	.014	18	view →
HNSC	DFS	Tertile	IV	0.050	0.570	<.001	18	view →
LUSC	OS	Tertile	III,IV	0.140	0.664	.016	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
ESCA	DFS	Tertile	All	0.151	0.739	.006	12	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
READ	OS	Tertile	All	0.282	0.843	.002	9	view →
LUAD	OS	Tertile	III,IV	0.228	0.677	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MTCO3P9–SKCM (DFS)

Open the SKCM breakdown →